Clinical Trial Update: The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding pembrolizumab to postoperative radiotherapy in cutaneous squamous cell carcinoma of the head and neck; completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19